Our collaborative project with Dr. Chonghui Cheng’s lab, titled “Targeting Cryptic Splicing-Derived Neoantigens in hnRNPM-Dysregulated Triple-Negative Breast Cancer,” has been selected for a DoD Breakthrough Award.
News Story
News Story
Our collaborative project with Dr. Chonghui Cheng’s lab, titled “Targeting Cryptic Splicing-Derived Neoantigens in hnRNPM-Dysregulated Triple-Negative Breast Cancer,” has been selected for a DoD Breakthrough Award.